Andre Abreu-Bento
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Modeling the clinical and economic impact of universal varicella vaccination in Belgium with dynamic population.
Journal: PLOS global public health
Published: May 14, 2025
The Health Impact of Using Anti-PD-1 Agents to Treat Early-Stage Cancer in Belgium.
Journal: Oncology and therapy
Published: May 13, 2025
Fiscal analysis of the pediatric immunization program in Belgium applying a lifetime government perspective framework.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: January 17, 2024
Estimating the lifetime cost of vaccination in 23 European Countries: a modeling study.
Journal: Expert review of vaccines
Published: December 15, 2022
Public health impact and return on investment of Belgium's pediatric immunization program.
Journal: Frontiers in public health
Published: August 30, 2022
Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium.
Journal: Frontiers in pharmacology
Published: November 11, 2020
AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS.
Journal: Molecular therapy. Methods & clinical development
Published: August 18, 2020
Elongator subunit 3 (ELP3) modifies ALS through tRNA modification.
Journal: Human molecular genetics
Published: October 24, 2017
A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism.
Journal: Acta neuropathologica
Published: July 31, 2017
Genetic ablation of IP3 receptor 2 increases cytokines and decreases survival of SOD1G93A mice.
Journal: Human molecular genetics
Published: March 19, 2016
Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
Journal: Neurobiology of disease
Published: June 13, 2013
Rapamycin increases survival in ALS mice lacking mature lymphocytes.
Journal: Molecular neurodegeneration
Published: April 16, 2013
Last Updated: 09/26/2026